A citation-based method for searching scientific literature

Laufey Tryggvadóttir, Linda Vidarsdóttir, Tryggvi Thorgeirsson, Jon Gunnlaugur Jonasson, Elinborg Jona Olafsdóttir, Gudridur Helga Olafsdóttir, Thorunn Rafnar, Steinunn Thorlacius, Eirikur Jonsson, Jorunn Erla Eyfjord, Hrafn Tulinius. J Natl Cancer Inst 2007
Times Cited: 147







List of co-cited articles
875 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
383
60

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
David J Gallagher, Mia M Gaudet, Prodipto Pal, Tomas Kirchhoff, Lisa Balistreri, Kinjal Vora, Jasmine Bhatia, Zsofia Stadler, Samson W Fine, Victor Reuter,[...]. Clin Cancer Res 2010
171
45

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.
Z Kote-Jarai, D Leongamornlert, E Saunders, M Tymrakiewicz, E Castro, N Mahmud, M Guy, S Edwards, L O'Brien, E Sawyer,[...]. Br J Cancer 2011
226
41

Rapid progression of prostate cancer in men with a BRCA2 mutation.
S A Narod, S Neuhausen, G Vichodez, S Armel, H T Lynch, P Ghadirian, S Cummings, O Olopade, D Stoppa-Lyonnet, F Couch,[...]. Br J Cancer 2008
97
39

Germline BRCA1 mutations increase prostate cancer risk.
D Leongamornlert, N Mahmud, M Tymrakiewicz, E Saunders, T Dadaev, E Castro, C Goh, K Govindasami, M Guy, L O'Brien,[...]. Br J Cancer 2012
168
37

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.
Heather Thorne, Amber J Willems, Eveline Niedermayr, Ivan M Y Hoh, Jason Li, David Clouston, Gillian Mitchell, Stephen Fox, John L Hopper, Damien Bolton. Cancer Prev Res (Phila) 2011
76
47


Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
S M Edwards, D G R Evans, Q Hope, A R Norman, Y Barbachano, S Bullock, Z Kote-Jarai, J Meitz, A Falconer, P Osin,[...]. Br J Cancer 2010
103
34

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
34

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
675
33

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype.
A Mitra, C Fisher, C S Foster, C Jameson, Y Barbachanno, J Bartlett, E Bancroft, R Doherty, Z Kote-Jarai, S Peock,[...]. Br J Cancer 2008
99
32

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014
149
32

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.
Elena Castro, Chee Goh, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Steve Ellis, Debra Frost,[...]. Eur Urol 2015
172
31

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
28

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin, Rachel Jackson, Christine Southgate, Rashmi Singh, Alison Falconer,[...]. Am J Hum Genet 2003
251
25

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
361
23

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
714
23

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009
82
25

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.
Anita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, Elizabeth C Page, C S Foster, C Jameson, G Mitchell, G J Lindeman, A Stapleton, G Suthers,[...]. BJU Int 2011
68
29

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005
262
19

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
261
19

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
I Agalliu, E Karlins, E M Kwon, L M Iwasaki, A Diamond, E A Ostrander, J L Stanford. Br J Cancer 2007
70
22

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer.
M R Akbari, C J D Wallis, A Toi, J Trachtenberg, P Sun, S A Narod, R K Nam. Br J Cancer 2014
46
34

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
157
16


BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Tomas Kirchhoff, Noah D Kauff, Nandita Mitra, Kedoudja Nafa, Helen Huang, Crystal Palmer, Tony Gulati, Eve Wadsworth, Sheri Donat, Mark E Robson,[...]. Clin Cancer Res 2004
105
15

Screening and prostate-cancer mortality in a randomized European study.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa,[...]. N Engl J Med 2009
15

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology.
R M Giusti, J L Rutter, P H Duray, L S Freedman, M Konichezky, J Fisher-Fischbein, M H Greene, B Maslansky, A Fischbein, S B Gruber,[...]. J Med Genet 2003
63
23

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
15

Mortality results from a randomized prostate-cancer screening trial.
Gerald L Andriole, E David Crawford, Robert L Grubb, Saundra S Buys, David Chia, Timothy R Church, Mona N Fouad, Edward P Gelmann, Paul A Kvale, Douglas J Reding,[...]. N Engl J Med 2009
14

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.
Heather H Cheng, Colin C Pritchard, Thomas Boyd, Peter S Nelson, Bruce Montgomery. Eur Urol 2016
169
14

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Scott A Tomlins, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, Xuhong Cao, Joelle Tchinda, Rainer Kuefer,[...]. Science 2005
13

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, Edward J Saunders, Daniel A Leongamornlert, Malgorzata Tymrakiewicz, Maya Ghoussaini, Craig Luccarini, Joe Dennis, Sarah Jugurnauth-Little,[...]. Nat Genet 2013
398
13

Cumulative association of five genetic variants with prostate cancer.
S Lilly Zheng, Jielin Sun, Fredrik Wiklund, Shelly Smith, Pär Stattin, Ge Li, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Katarina Bälter,[...]. N Engl J Med 2008
471
12


Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
12

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
12

Elevated risk of prostate cancer among men with Lynch syndrome.
Victoria M Raymond, Bhramar Mukherjee, Fei Wang, Shu-Chen Huang, Elena M Stoffel, Fay Kastrinos, Sapna Syngal, Kathleen A Cooney, Stephen B Gruber. J Clin Oncol 2013
102
12


Mendelian inheritance of familial prostate cancer.
B S Carter, T H Beaty, G D Steinberg, B Childs, P C Walsh. Proc Natl Acad Sci U S A 1992
532
11

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
11

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
A Moran, C O'Hara, S Khan, L Shack, E Woodward, E R Maher, F Lalloo, D G R Evans. Fam Cancer 2012
163
11

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Renea A Taylor, Michael Fraser, Julie Livingstone, Shadrielle Melijah G Espiritu, Heather Thorne, Vincent Huang, Winnie Lo, Yu-Jia Shiah, Takafumi N Yamaguchi, Ania Sliwinski,[...]. Nat Commun 2017
114
11

BRCA2 mutation in Icelandic prostate cancer patients.
S Sigurdsson, S Thorlacius, J Tomasson, L Tryggvadottir, K Benediktsdottir, J E Eyfjörd, E Jonsson. J Mol Med (Berl) 1997
98
10

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
123
10

Prostate cancer incidence in males with Lynch syndrome.
Sigurdis Haraldsdottir, Heather Hampel, Lai Wei, Christina Wu, Wendy Frankel, Tanios Bekaii-Saab, Albert de la Chapelle, Richard M Goldberg. Genet Med 2014
63
15

The heritability of prostate cancer in the Nordic Twin Study of Cancer.
Jacob B Hjelmborg, Thomas Scheike, Klaus Holst, Axel Skytthe, Kathryn L Penney, Rebecca E Graff, Eero Pukkala, Kaare Christensen, Hans-Olov Adami, Niels V Holm,[...]. Cancer Epidemiol Biomarkers Prev 2014
102
10

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Z Kote-Jarai, C Mikropoulos, D A Leongamornlert, T Dadaev, M Tymrakiewicz, E J Saunders, M Jones, S Jugurnauth-Little, K Govindasami, M Guy,[...]. Ann Oncol 2015
53
18

An inherited NBN mutation is associated with poor prognosis prostate cancer.
C Cybulski, D Wokołorczyk, W Kluźniak, A Jakubowska, B Górski, J Gronwald, T Huzarski, A Kashyap, T Byrski, T Dębniak,[...]. Br J Cancer 2013
51
19

Familial Risk and Heritability of Cancer Among Twins in Nordic Countries.
Lorelei A Mucci, Jacob B Hjelmborg, Jennifer R Harris, Kamila Czene, David J Havelick, Thomas Scheike, Rebecca E Graff, Klaus Holst, Sören Möller, Robert H Unger,[...]. JAMA 2016
312
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.